Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques (Q43699664)

26 November 2017

Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques (English)

1 reference

26 November 2017

5

Barry PA

1 reference

26 November 2017

Loomis-Huff JE

1

1 reference

26 November 2017

Eberle R

series ordinal

2

1 reference

26 November 2017

Lockridge KM

series ordinal

3

1 reference

26 November 2017

Rhodes G

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

19

1 reference

26 November 2017

4865-4873

1 reference

26 November 2017

32

1 reference

Biology of B Virus in Macaque and Human Hosts: A Review

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Guidelines for the prevention and treatment of B-virus infections in exposed persons. The B virus Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

ACUTE ASCENDING MYELITIS FOLLOWING A MONKEY BITE, WITH THE ISOLATION OF A VIRUS CAPABLE OF REPRODUCING THE DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

AIDS research. Vaccine studies stymied by shortage of animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Protection against herpes B virus infection in rabbits with a recombinant vaccinia virus expressing glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Herpes simplex virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

1 reference

7 January 2021

Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

DNA immunization of neonates induces immunity despite the presence of maternal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunization by both parenteral and mucosal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Protective immune correlates can segregate by vaccine type in a murine herpes model system.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Herpes simplex virus DNA vaccine efficacy: effect of glycoprotein D plasmid constructs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

DNA immunization protects nonhuman primates against rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Protection from pathogenic SIV challenge using multigenic DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

1 reference

7 January 2021

DNA immunization: mechanistic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

The influence of base sequence on the immunostimulatory properties of DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Genetic and functional complementation of the HSV1 UL27 gene and gB glycoprotein by simian alpha-herpesvirus homologs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Relative Titers of Antibodies to Individual Polypeptide Antigens of Herpes Simplex Virus Type 1 in Human Sera

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Analysis of the IgM and IgG antibody response against herpes simplex virus type 1 (HSV-1) structural and nonstructural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Characterization of virus-specific and cross-reactive monoclonal antibodies to Herpesvirus simiae (B virus).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Pathogenesis of experimental rhesus cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Biological features of genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Chromatographic fractionation of rhesus monkey (Macaca mulatta) IgG subclasses using deae cellulose and protein A-sepharose

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Nucleic acid immunization: concepts and techniques associated with third generation vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Immunization of non-human primates with DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Intradermal DNA immunization by using jet-injectors in mice and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Immunization against SIVmne in macaques using multigenic DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Tipping the scales of herpes simplex virus reactivation: the important responses are local

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900232-8

7 January 2021

10.1016/S0264-410X(01)00232-8

Identifiers

DOI

1 reference

26 November 2017

1 reference